BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20096133)

  • 1. Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.
    Gärtner R; Cronin-Fenton D; Hundborg HH; Pedersen L; Lash TL; Sørensen HT; Kroman N
    BMC Surg; 2010 Jan; 10():3. PubMed ID: 20096133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients: a Danish population-based cohort study.
    Thomsen AML; Pedersen AB; Kristensen NR; Møller BK; Erikstrup C; Christiansen PM; Nørgaard M; Cronin-Fenton D
    Breast Cancer Res; 2017 Dec; 19(1):135. PubMed ID: 29273074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.
    Winther Lietzen L; Cronin-Fenton D; Garne JP; Kroman N; Silliman R; Lash TL
    Eur J Surg Oncol; 2012 May; 38(5):407-12. PubMed ID: 22429495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery.
    Andreasen JJ; Riis A; Hjortdal VE; Jørgensen J; Sørensen HT; Johnsen SP
    Am J Cardiovasc Drugs; 2006; 6(4):243-50. PubMed ID: 16913825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
    Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
    Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
    Tully PJ; Cardinal T; Bennetts JS; Baker RA
    Heart Lung Circ; 2012 Apr; 21(4):206-14. PubMed ID: 22285303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study.
    Lindqvist PG; Nasiell J; Gustafsson LL; Nordstrom L
    J Thromb Haemost; 2014 Dec; 12(12):1986-92. PubMed ID: 25322909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study.
    Bruun SB; Petersen I; Kristensen NR; Cronin-Fenton D; Pedersen AB
    Clin Epidemiol; 2018; 10():1053-1071. PubMed ID: 30214311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting.
    Xiong GL; Jiang W; Clare RM; Shaw LK; Smith PK; O'Connor CM; Ranga K; Krishnan R; Kristin Newby L
    Clin Cardiol; 2010 Jun; 33(6):E94-8. PubMed ID: 20552618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study.
    Nørgaard M; Jacobsen J; Gasse C; Pedersen L; Mortensen PB; Sørensen HT
    J Clin Psychopharmacol; 2007 Jun; 27(3):259-62. PubMed ID: 17502772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
    Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
    Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of selective serotonin reuptake inhibitors antidepressants and bleeding risk in breast cosmetic surgery.
    Basile FV; Basile AR; Basile VV
    Aesthetic Plast Surg; 2013 Jun; 37(3):561-6. PubMed ID: 23571783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.
    Dalton SO; Johansen C; Mellemkjaer L; Nørgård B; Sørensen HT; Olsen JH
    Arch Intern Med; 2003 Jan; 163(1):59-64. PubMed ID: 12523917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do selective serotonin reuptake inhibitors increase the risk of bleeding or mortality following coronary artery bypass graft surgery? A meta-analysis of observational studies.
    Eckersley MJ; Sepehripour AH; Casula R; Punjabi P; Athanasiou T
    Perfusion; 2018 Sep; 33(6):415-422. PubMed ID: 29569518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-Modulating Antidepressants and Risk of Bleeding after Trauma.
    Wilson LB; Cox MR; Benns MV; Pinkston CM; Scherrer LA
    Am Surg; 2018 Nov; 84(11):1727-1733. PubMed ID: 30747624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk: A Review of the Literature.
    Roose SP; Rutherford BR
    J Clin Psychopharmacol; 2016 Dec; 36(6):704-709. PubMed ID: 27684291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study.
    Bak S; Tsiropoulos I; Kjaersgaard JO; Andersen M; Mellerup E; Hallas J; García Rodríguez LA; Christensen K; Gaist D
    Stroke; 2002 Jun; 33(6):1465-73. PubMed ID: 12052976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding.
    Dall M; Schaffalitzky de Muckadell OB; Lassen AT; Hansen JM; Hallas J
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1314-21. PubMed ID: 19716436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England.
    Layton D; Clark DW; Pearce GL; Shakir SA
    Eur J Clin Pharmacol; 2001 May; 57(2):167-76. PubMed ID: 11417450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies.
    Laporte S; Chapelle C; Caillet P; Beyens MN; Bellet F; Delavenne X; Mismetti P; Bertoletti L
    Pharmacol Res; 2017 Apr; 118():19-32. PubMed ID: 27521835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.